Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 4198035, 21 pages
https://doi.org/10.1155/2017/4198035
Research Article

Systems Pharmacological Approach of Pulsatillae Radix on Treating Crohn’s Disease

Department of Pharmacology, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam 50612, Republic of Korea

Correspondence should be addressed to Won G. An

Received 20 January 2017; Revised 28 February 2017; Accepted 1 March 2017; Published 1 June 2017

Academic Editor: Jae Youl Cho

Copyright © 2017 Su Yeon Suh and Won G. An. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Baumgart, Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach, Springer Science & Business Media, 2012.
  2. D. C. Baumgart and W. J. Sandborn, “Crohn's disease,” The Lancet, vol. 380, no. 9853, pp. 1590–1605, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. W. C. Tan and R. N. Allan, “Diffuse jejunoileitis of Crohn's disease,” Gut, vol. 34, no. 10, pp. 1374–1378, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Dessein, M. Chamaillard, and S. Danese, “Innate immunity in Crohn’s disease: the reverse side of the medal,” Journal of Clinical Gastroenterology, vol. 42, supplement 3, pp. S144–S147, 2008. View at Google Scholar
  5. D. N. Floyd, S. Langham, H. C. Séverac, and B. G. Levesque, “The economic and quality-of-life burden of crohn’s disease in Europe and the United States, 2000 to 2013: a systematic review,” Digestive Diseases and Sciences, vol. 60, no. 2, pp. 299–312, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. B. Marks, F. Z. Rahman, G. W. Sewell, and A. W. Segal, “Crohn's disease: an immune deficiency state,” Clinical Reviews in Allergy & Immunology, vol. 38, no. 1, pp. 20–31, 2010. View at Publisher · View at Google Scholar
  7. T. Stefanelli, A. Malesci, A. Repici, S. Vetrano, and S. Danese, “New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets,” Current Drug Targets, vol. 9, no. 5, pp. 413–418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Hayee, F. Z. Rahman, G. Sewell, A. M. Smith, and A. W. Segal, “Crohn's disease as an immunodeficiency,” Expert Review of Clinical Immunology, vol. 6, no. 4, pp. 585–596, 2010. View at Publisher · View at Google Scholar
  9. A. N. Ananthakrishnan, R. J. Xavier, and D. K. Podolsky, “Inflammatory bowel diseases: pathogenesis,” Yamada's Textbook of Gastroenterology, pp. 1364–1377, 2016. View at Publisher · View at Google Scholar
  10. S. C. Ng, Y. T. Lam, K. K. F. Tsoi, F. K. L. Chan, J. J. Y. Sung, and J. C. Y. Wu, “Systematic review: the efficacy of herbal therapy in inflammatory bowel disease,” Alimentary Pharmacology and Therapeutics, vol. 38, no. 8, pp. 854–863, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Sałaga, H. Zatorski, M. Sobczak, C. Chen, and J. Fichna, “Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review,” Current Treatment Options in Oncology, vol. 15, no. 3, pp. 405–420, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-H. Kim, “Anti-inflammatory effect of Pulsatilla koreana,” pp. 1–49, 2008.
  13. L. Y.-M. K. Hyo-Jin, “Pulsatilla koreana ethanol extract suppress adipocyte differentiation and adipogenesis via down-regulation of PPAR-γ and C/EBPs,” pp. 1–47, 2014.
  14. W. Li, Y. Ding, Y. N. Sun et al., “Oleanane-type triterpenoid saponins from the roots of Pulsatilla koreana and their apoptosis-inducing effects on HL-60 human promyelocytic leukemia cells,” Archives of Pharmacal Research, vol. 36, no. 6, pp. 768–774, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Li, Y. Ding, Y. N. Sun et al., “Triterpenoid saponins of pulsatilla koreana root have inhibition effects of tumor necrosis factor-α secretion in lipopolysaccharide-induced RAW264.7 cells,” Chemical and Pharmaceutical Bulletin, vol. 61, no. 4, pp. 471–476, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. B. H. Park, K. H. Jung, M. K. Son et al., “Antitumor activity of Pulsatilla koreana extract in anaplastic thyroid cancer via apoptosis and anti-angiogenesis,” Molecular Medicine Reports, vol. 7, no. 1, pp. 26–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. H. Lee, E. Lee, and Y. T. Ko, “Anti-inflammatory effects of a methanol extract from Pulsatilla koreana in lipopolysaccharide-exposed rats,” BMB Reports, vol. 45, no. 6, pp. 371–376, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Zhao, Y. Li, X. Wang, and W. J. Sun, “The experimental study of Cortex Eucommiae on meridian tropsim: the distribution study of aucubin in rat tissues,” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 2, pp. 368–373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. Y.-X. Chang, Y.-G. Sun, J. Li et al., “The experimental study of Astragalus membranaceus on meridian tropsim: The distribution study of astragaloside IV in rat tissues,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 911, pp. 71–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Shen, S. Tian, Y. Li et al., “Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines,” Journal of Cheminformatics, vol. 4, no. 1, article 31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Xu, W. Zhang, C. Huang et al., “A novel chemometric method for the prediction of human oral bioavailability,” International Journal of Molecular Sciences, vol. 13, no. 6, pp. 6964–6982, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Hubatsch, E. G. E. Ragnarsson, and P. Artursson, “Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers,” Nature Protocols, vol. 2, no. 9, pp. 2111–2119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Tao, X. Xu, X. Wang et al., “Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease,” Journal of Ethnopharmacology, vol. 145, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Zhang, Y. Li, S.-S. Chen et al., “Systems pharmacology dissection of the anti-inflammatory mechanism for the medicinal herb Folium eriobotryae,” International Journal of Molecular Sciences, vol. 16, no. 2, pp. 2913–2941, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Willett, J. M. Barnard, and G. M. Downs, “Chemical similarity searching,” Journal of Chemical Information and Computer Sciences, vol. 38, no. 6, pp. 983–996, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Liu, J. Wang, W. Zhou, Y. Wang, and L. Yang, “Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice,” Journal of Ethnopharmacology, vol. 146, no. 3, pp. 773–793, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. K. S. Pang, “Modeling of intestinal drug absorption: Roles of transporters and metabolic enzymes (for the gillette review series),” Drug Metabolism & Disposition, vol. 31, no. 12, pp. 1507–1519, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Pei, C. Zheng, C. Huang et al., “Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula,” Journal of Ethnopharmacology, vol. 190, pp. 272–287, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Yu, J. Chen, X. Xu et al., “A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data,” PLoS ONE, vol. 7, no. 5, Article ID e37608, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. C. H. Wu, R. Apweiler, A. Bairoch et al., “The Universal Protein Resource (UniProt): an expanding universe of protein information,” Nucleic Acids Research, vol. 34, no. Database issue, pp. D187–D191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Bindea, B. Mlecnik, H. Hackl et al., “ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks,” Bioinformatics, vol. 25, no. 8, pp. 1091–1093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. E. Smoot, K. Ono, J. Ruscheinski, P. L. Wang, and T. Ideker, “Cytoscape 2.8: new features for data integration and network visualization,” Bioinformatics, vol. 27, no. 3, pp. 431-432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J.-B. Pan, S.-C. Hu, D. Shi et al., “PaGenBase: a pattern gene database for the global and dynamic understanding of gene function,” PLoS ONE, vol. 8, no. 12, Article ID e80747, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Zhang, Q. Tao, Z. Guo et al., “Systems pharmacology dissection of the integrated treatment for cardiovascular and gastrointestinal disorders by traditional chinese medicine,” Scientific Reports, vol. 6, p. 32400, 2016. View at Publisher · View at Google Scholar
  35. Z. Prevoršek, G. Gorjanc, B. Paigen, and S. Horvat, “Congenic and bioinformatics analyses resolved a major-effect Fob3b QTL on mouse Chr 15 into two closely linked loci,” Mammalian Genome, vol. 21, no. 3-4, pp. 172–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Senthil Kumar and R. Kumaresan, “A comparative study on the antioxidant properties of bractein and cernuoside by the DFT method,” Monatshefte fur Chemie, vol. 144, no. 10, pp. 1513–1524, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Guo, Y.-X. Deng, H. Xie et al., “Antinociceptive and anti-inflammatory activities of ethyl acetate fraction from Zanthoxylum armatum in mice,” Fitoterapia, vol. 82, no. 3, pp. 347–351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Kmiecik, J. Korczak, M. Rudzińska, J. Kobus-Cisowska, A. Gramza-Michałowska, and M. Hȩś, “β-Sitosterol and campesterol stabilisation by natural and synthetic antioxidants during heating,” Food Chemistry, vol. 128, no. 4, pp. 937–942, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. H. Choi and G. H. Yan, “Anti-allergic effects of scoparone on mast cell-mediated allergy model,” Phytomedicine, vol. 16, no. 12, pp. 1089–1094, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. K. S. Kumar and R. Kumaresan, “A quantum chemical study on the antioxidant properties of aureusidin and bracteatin,” International Journal of Quantum Chemistry, vol. 111, no. 15, pp. 4483–4496, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Roussaki, A. Gaitanarou, P. C. Diamanti et al., “Encapsulation of the natural antioxidant aureusidin in biodegradable PLA nanoparticles,” Polymer Degradation and Stability, vol. 108, pp. 182–187, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. Q. Yanping, “Effects of velvet for the tumor and immune function in tumor-bearing mice,” Journal of Heilongjiang Bayi Agricultural University, vol. 1, p. 17, 2012. View at Google Scholar
  43. F. Dan and Z. C. Bin, “The anti-tumor effect of the extract from Radix Pulsatillae,” Chinese Journal of Hospital Pharmacy, vol. 9, p. 009, 2003. View at Google Scholar
  44. S. F. Vasilevsky, A. I. Govdi, I. V. Sorokina et al., “Rapid access to new bioconjugates of betulonic acid via click chemistry,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 1, pp. 62–65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Lee, J.-C. Jung, Z. Ali, I. A. Khan, and S. Oh, “Anti-inflammatory effect of triterpene saponins isolated from blue cohosh (caulophyllum thalictroides),” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 798192, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Chen, Y.-B. Ji, D.-X. Song, C.-R. Xu, H. Song, and J. Li, “Effects of Dauricine concentration in asiatic moonseed by different extraction solvents and methods,” Applied Mechanics and Materials, vol. 411–414, pp. 3162–3165, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Ma, H. Chen, P. Dong, and X. Lu, “Anti-inflammatory and anticancer activities of extracts and compounds from the mushroom Inonotus obliquus,” Food Chemistry, vol. 139, no. 1–4, pp. 503–508, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Boesch-Saadatmandi, A. Loboda, A. E. Wagner et al., “Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155,” Journal of Nutritional Biochemistry, vol. 22, no. 3, pp. 293–299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Liu, “Oleanolic acid and ursolic acid: research perspectives,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 92–94, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. S.-J. Tsai and M.-C. Yin, “Antioxidative and anti-inflammatory protection of oleanolic acid and ursolic acid in PC12 cells,” Journal of Food Science, vol. 73, no. 7, pp. H174–H178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Liu, T. Pei, J. Mu et al., “Systems pharmacology uncovers the multiple mechanisms of Xijiao Dihuang decoction for the treatment of viral hemorrhagic fever,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 9025036, 17 pages, 2016. View at Publisher · View at Google Scholar
  52. S. I. Berger and R. Iyengar, “Network analyses in systems pharmacology,” Bioinformatics, vol. 25, no. 19, pp. 2466–2472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Li, L.-W. Qi, E.-H. Liu, J.-L. Zhou, and X.-D. Wen, “Analysis of Chinese herbal medicines with holistic approaches and integrated evaluation models,” TrAC—Trends in Analytical Chemistry, vol. 27, no. 1, pp. 66–77, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. L. M. Espinoza-Fonseca, “The benefits of the multi-target approach in drug design and discovery,” Bioorganic and Medicinal Chemistry, vol. 14, no. 4, pp. 896-897, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. P. P. Tak and G. S. Firestein, “NF-κB: a key role in inflammatory diseases,” Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Xiao, D. R. Hodge, L. Wang, X. Yang, X. Zhang, and W. L. Farrar, “NF-κB activates IL-6 expression through cooperation with c-Jun and IL6-AP1 site, but is independent of its IL6-NFκB regulatory site in autocrine human multiple myeloma cells,” Cancer Biology & Therapy, vol. 3, no. 10, pp. 1007–1017, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. C. K. Glass and K. Saijo, “Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells,” Nature Reviews Immunology, vol. 10, no. 5, pp. 365–376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Mitsuyama, S. Matsumoto, J. Masuda et al., “Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease,” Anticancer Research, vol. 27, no. 6A, pp. 3749–3756, 2007. View at Google Scholar · View at Scopus
  59. K. Yamazaki, J. Umeno, A. Takahashi et al., “A genome-wide association study identifies 2 susceptibility loci for Crohn's disease in a Japanese population,” Gastroenterology, vol. 144, no. 4, pp. 781–788, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Costa, M. G. Mumolo, L. Ceccarelli et al., “Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease,” Gut, vol. 54, no. 3, pp. 364–368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. M. E. Ament, “Inflammatory disease of the colon: ulcerative colitis and Crohn's colitis,” The Journal of Pediatrics, vol. 86, no. 3, pp. 322–334, 1975. View at Publisher · View at Google Scholar · View at Scopus
  62. I. Kristo, A. Stift, M. Bergmann, and S. Riss, “Surgical recurrence in Crohn's disease: are we getting better?” World Journal of Gastroenterology, vol. 21, no. 20, pp. 6097–6100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Elder, C. Ritenbaugh, M. Aickin et al., “Reductions in pain medication use associated with traditional Chinese medicine for chronic pain,” Issues, vol. 16, pp. 18–23, 2016. View at Google Scholar
  64. M. Tan, M. Win, and S. A. Khan, “The use of complementary and alternative medicine in chronic pain patients in Singapore: a single-centre study,” Annals of the Academy of Medicine, Singapore, vol. 42, no. 3, pp. 133–137, 2013. View at Google Scholar
  65. M. A. Behr, M. Divangahi, and J.-D. Lalande, “What's in a name? The (mis)labelling of Crohn's as an autoimmune disease,” The Lancet, vol. 376, no. 9736, pp. 202-203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. K. M. Das and L. Biancone, “Is IBD an autoimmune disorder?” Inflammatory Bowel Diseases, vol. 14, no. S2, pp. S97–S101, 2008. View at Google Scholar
  67. B. B. Crohn, L. Ginzburg, and G. D. Oppenheimer, “Regional ileitis: a pathologic and clinical entity,” Journal of the American Medical Association, vol. 99, no. 16, pp. 1323–1329, 1932. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Riaz, R. A. Khan, S. Ahmed, and S. Afroz, “Assessment of acute toxicity and reproductive capability of a herbal combination,” Pakistan Journal of Pharmaceutical Sciences, vol. 23, no. 3, pp. 291–294, 2010. View at Google Scholar
  69. H. U. Kim, J. Y. Ryu, J. O. Lee, and S. Y. Lee, “A systems approach to traditional oriental medicine,” Nature Biotechnology, vol. 33, no. 3, pp. 264–268, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. H.-Y. Hsieh, P.-H. Chiu, and S.-C. Wang, “Epigenetics in traditional chinese pharmacy: a bioinformatic study at pharmacopoeia scale,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 816714, 10 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Omenetti, M. Brogi, R. Garg et al., “Essential role for Toll-like receptor 9 in the pathogenesis of liver inflammation in a murine model of Crohns disease-like ileitis (P3147),” The Journal of Immunology, vol. 190, no. 1 supplement, pp. 35–43, 2013. View at Google Scholar
  72. S. H. Mir-Madjlessi, M. C. McHenry, and R. G. Farmer, “Liver abscess in Crohn's disease. Report of four cases and review of the literature,” Gastroenterology, vol. 91, no. 4, pp. 987–993, 1986. View at Publisher · View at Google Scholar · View at Scopus
  73. A. D. Perrett, G. Higgins, H. H. Johnston et al., “The liver in Crohn's disease,” Gastroenterology, vol. 40, no. 158, pp. 187–209, 1971. View at Publisher · View at Google Scholar
  74. M. N. Eade, W. T. Cooke, and I. A. Williams, “Liver disease in crohn's disease: a study of 100 consecutive patients,” Scandinavian Journal of Gastroenterology, vol. 6, no. 3, pp. 199–204, 1971. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Carvalheiro, S. Mendes, and C. Sofia, “Infliximab induced liver injury in Crohn's disease: a challenging diagnosis,” Journal of Crohn's and Colitis, vol. 8, no. 5, pp. 436-437, 2014. View at Publisher · View at Google Scholar · View at Scopus